With the right partner to help you harness the many benefits, nasal delivery is not to be sniffed at.

New EU “transparency” measures give member states the power to block vaccine exports if manufacturers can’t meet contractual obligations.

Mice with severed spinal cords walk again after gene therapy.

Everything cell + gene therapy – in five minutes.

Ewoud van Tricht explores three novel methods that could streamline the development of adenovirus vaccines for COVID-19 at Janssen.

Facilities must be flexible enough to cope with multiple modalities, including cell and gene therapies.

We sit down with the British Generics Manufacturers Association's Warwick Smith.

Big Data opens the door to even smarter cell therapies.

Sitting down with Janssen's David Lee to discuss a new era in immunology R&D.

What factors are driving pharma's move towards digital marketing?